Keros Therapeutics Inc
KROS
Market Cap$547.9M
Close$
$13.86
3.8% upside
Current Fair Value
3.8% upsideUndervalued by 3.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $547.90 Million |
|---|---|
| Enterprise Value | $-140,875,254.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5 |
| Beta | 1.3 |
| Outstanding Shares | 40,559,355 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 129.9 |
|---|---|
| PEG | -29.24 |
| Price to Sales | 2.67 |
| Price to Book Ratio | 0.79 |
| Enterprise Value to Revenue | -0.66 |
| Enterprise Value to EBIT | 35.04 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | -0.23 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data